Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Vespireit, Prolonged-release Tablets, in Patients With Autonomic Dysfunction Syndrome Accompanied by Functional Vertigo	Ear Diseases, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Vertigo, autonomic nervous system disorder, inner ear disorder, nervous system disorder, otorhinolaryngologic disease, primary dysautonomia, vestibular disorder	Recruiting	Phase 4	2025-06-15		NCT06321341

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Valenta Pharm JSC	12

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Central Clinic LLC	Bryansk	Russia	1
Federal State Budgetary Educational Institution of Higher Education "Kirov State Medical University" of the Ministry of Healthcare of the Russian Federation	Kirov	Russia	2
Private Healthcare Institution "Clinical Hospital "RZD-Medicine" of the city of Smolensk"	Smolensk	Russia	1
State Budgetary Institution of Healthcare of the City of Moscow "V.P. Demikhov City Clinical Hospital of the Department of Healthcare of the City of Moscow"	Moscow	Russia	1